文献速递神经核医学

衰减和散射校正对临床不确定帕金森综合征患者多巴胺转运体SPECT解读无影响

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-06-17

结果显示,同一读片者有无ASC分类不一致比例约1.66%±0.50%,未超过读片者自身变异基准2.2%;基于壳核SBR的自动分类不一致比例为1.78%。结论认为ASC对DAT-SPECT检测黑质纹状体变性的临床效用无相关影响。

要点

  • 同一读片者有无ASC分类不一致比例1.66%±0.50%,未超过读片者自身变异基准约2.2%。
  • 基于壳核SBR的自动分类有无ASC不一致比例1.78%。

核心结论

  • 基于大样本,当前发现提供强证据表明,采用均匀衰减图和模拟散射校正的ASC对DAT-SPECT检测临床不确定帕金森综合征患者黑质纹状体变性的临床效用无相关影响。

研究设计与样本

  • 由三名独立读片者按有无帕金森典型纹状体123I-FP-CIT摄取降低进行分类,每份图像读片两次以评估读片者自身变异。
  • 使用特定123I-FP-CIT结合比值(SBR)进行自动分类,分别在有和无ASC条件下进行。

主要发现

  • 同一读片者两次读片间分类不一致的平均比例在无ASC和有ASC时几乎相同,约为2.2%。
  • 同一读片者无ASC versus 有ASC分类不一致的DAT-SPECT比例为1.66%±0.50%(范围1.09-1.95%),未超过读片者自身变异的基准2.2%。
  • 基于壳核SBR的DAT-SPECT图像自动分类中,无ASC versus 有ASC的不一致病例比例为1.78%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The benefit from attenuation and scatter correction (ASC) of dopamine transporter (DAT)-SPECT for the detection of nigrostriatal degeneration in clinical routine is still a matter of debate. The current study evaluated the impact of ASC on visual interpretation and semi-quantitative analysis of DAT-SPECT in a large patient sample. METHODS: One thousand seven hundred forty consecutive DAT-SPECT with 123I-FP-CIT from clinical routine were included retrospectively. SPECT images were reconstructed iteratively without and with ASC. Attenuation correction was based on uniform attenuation maps, scatter correction on simulation. All SPECT images were categorized with respect to the presence versus the absence of Parkinson-typical reduction of striatal 123I-FP-CIT uptake by three independent readers. Image reading was performed twice to assess intra-reader variability. The specific 123I-FP-CIT binding ratio (SBR) was used for automatic categorization, separately with and without ASC. RESULTS: The mean proportion of cases with discrepant categorization by the same reader between the two reading sessions was practically the same without and with ASC, about 2.2%. The proportion of DAT-SPECT with discrepant categorization without versus with ASC by the same reader was 1.66% ± 0.50% (1.09-1.95%), not exceeding the benchmark of 2.2% from intra-reader variability. This also applied to automatic categorization of the DAT-SPECT images based on the putamen SBR (1.78% discrepant cases between without versus with ASC). CONCLUSION: Given the large sample size, the current findings provide strong evidence against a relevant impact of ASC with uniform attenuation and simulation-based scatter correction on the clinical utility of DAT-SPECT to detect nigrostriatal degeneration in patients with clinically uncertain parkinsonian syndrome.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Schiebler T, Apostolova I, Mathies FL, et al. No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome. Eur J Nucl Med Mol Imaging. 2023. PMID: 37328621. doi:10.1007/s00259-023-06293-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。